It’s good to see more lawyers focused on genomics as related to causation in mass tort cases. A group from Goldberg Segalla just wrote about the topic as part of a broader paper on alternative causation issues. The article was published in Mealey’s Asbestos; it is: Defense Strategies For Alternative Causation Arguments In Asbestos Case,

Some scientific findings provide both opportunities and risks for litigants in mass tort cases. The point is highlighted by a new paper by Panou and colleagues published in mid- August in the Journal of Clinical Oncology. The paper concludes that a significant proportion (12%) of patients with malignant mesotheliomas carry inherited (germline) mutations in

For many years, astute observers  pointed out that “change” is the one constant in asbestos litigation. With that in mind, one might think about talc claims.

With the “change” factor  in mind, it’s also interesting to see what’s happening at the big picture level in molecular biology and genomics. The quote below is from a

After months of procedural wrangling and negotiations about settlement, the asbestos plaintiff’s bar has now attacked the Bestwall/Georgia-Pacific chapter 11 as a “bad faith” filing. The motion is online.

The motion sets out a broad attack. Among other things, the motion focuses attention on GP’s one-day use of a Texas statute to divide up

In September, 2016, multidisciplinary colleagues and I published and sold our second, in-depth and multidisciplinary analysis of the changes to and new directions in asbestos litigation.  The paper was anchored around law and science innovations, and implications for mass tort claiming. For that effort, I teamed with David Schwartz and other science people at Innovative

As the litigation industry continues to expand, efforts continue to recruit plaintiffs also continue. One example involves a meeting of various former workers who may have been exposed to asbestos and other substance at Bethlehem Steel. The  meeting was hosted by a plaintiff’s firm (Lipsitz, Pontario) and attended by Dr. Mark Udell,  as described in